CTOs on the Move

Still River Systems, Inc.

www.stillriversystems.com

 
Still River Systems is dedicated to providing physicians and their patients access to high quality, cost-effective proton therapy solutions, and to helping establish this superior treatment modality as a standard of care for patients worldwide.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Phadia US

Phadia US is a Portage, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mediatech Inc

Mediatech Inc is a Manassas, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Imaging Dynamics Company Ltd

IDC is a global medical imaging technology provider and innovative force in the high growth field of digital radiography (DR) technology. The Company has over 3,000 installations in 50 countries of its proprietary, award winning direct capture DR technology, which replaces conventional film-based diagnostic imaging and provides a cost-effective solution for medical facilities of all sizes to provide high quality diagnostic X-ray images and improve the level of healthcare for their patients. Throughout its history, IDC has been recognized by multiple industry organizations and research analysts such as: Frost & Sullivan and Deloitte Technology; for its dedication to innovation, global market growth, and customer focused value proposition. The Company has its corporate office in Calgary, Canada, a business office in Hong Kong, and a representative office in Beijing, China.

Medical Imaging Resources

Medical Imaging Resources is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vermillion

Vermillion`s vision is to become a recognized leader in the advancement of women`s health by providing innovative methods to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. We will develop and commercialize high-value, multi-marker, diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our global commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health.